http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CO-5271650-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b8be6a6c990669567cc455d32b00535e
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4713
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-095
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-06
filingDate 2000-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ba90b99e50b10c0eed570c697d4cca78
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c939d859b62f0271a726ef9ed352148e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_735c61f330ddfe212e4ed8a9068df8dd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aba0e5cf50a2fd40371eb90f6f9bb405
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_89412f15e1daf40c295ced568e735d06
publicationDate 2003-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CO-5271650-A1
titleOfInvention MODIFIED AND PEPTIDOMIMETIC PEPTIDES FOR USE IN IMMUNOTHERAPY
abstract A modified peptide derived from H-Arg-Ser-Phe-Thr-Leu-Ala-Ser-Ser-Glu-Thr-Gly-Val-Gly-OH (formula I) having the general formula Q-A1-A2-A3 -A4-A5-A6-A7-A8-A9-A10-A11-A12-A13-Z (formula II), where A1 to A13 correspond to the amino acids of formula I, Q corresponds to H and Z corresponds to OH , CHARACTERIZED because 1 to 6 modifications are selected from one or more of the groups a, b or c consisting of: a) substitution of 1-6, preferably 1-4 amino acids in A1 to A13 by unnatural amino acids or ß amino acids, b) substitution of one or more amide bonds by reduced amide bonds or isoesters of ethylene, c) substitutions in Q and / or Z: and optionally d) substitution by natural amino acids up to a total of 6 modifications.
priorityDate 1999-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6325
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559542

Total number of triples: 32.